A Study of Patients Who Develop HIV Infection After Enrolling in HIV Vaccine Trials or HIV Vaccine Preparedness Trials
Public ClinicalTrials.gov record NCT00029913. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Site Evaluation of Virologic, Immunologic, and Clinical Natural History of Participants Enrolled in Phase I and Phase II HIV-1 Vaccine Protocols or HIV-1 Vaccine Preparedness Cohorts Who Develop HIV-1 Infection Subsequent to Trial Enrollment
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Despite risk reduction counseling, some individuals in HIV vaccine trials or vaccine preparedness studies may engage in risk behavior that results in HIV infection. The purpose of the HVTN 403 study is to find out more about how persons respond to HIV infection if they have received an experimental HIV-1 vaccine before they became HIV infected. Some people in HVTN 403 received an experimental HIV vaccine as a participant in a clinical trial before getting infected with HIV. Other people in this study were in a vaccine preparedness study when they got infected with HIV. None of these individuals became infected with HIV as result of their participation in an HIV vaccine or vaccine preparedness study. HVTN 403 will compare immune responses between those who previously received an experimental HIV vaccine and those who did not. Information learned from this study may be important in guiding future developments of new HIV vaccines and other treatments for HIV and AIDS.
Study identification
- NCT ID
- NCT00029913
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 54 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2002
- Primary completion
- Jun 30, 2009
- Completion
- Jun 30, 2009
- Last update posted
- Sep 1, 2010
2002 – 2009
United States locations
- U.S. sites
- 15
- U.S. states
- 9
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Univ of Alabama at Birmingham | Birmingham | Alabama | 35294 | — |
| Mt Zion Hospital | San Francisco | California | 94102 | — |
| San Francisco Dept of Hlth / AIDS Office | San Francisco | California | 94102 | — |
| University of MD - Inst. of Human Virology (IHV) | Baltimore | Maryland | 21201 | — |
| Jhu-Cir/Dc | Baltimore | Maryland | 21205 | — |
| Johns Hopkins Univ | Baltimore | Maryland | 21205 | — |
| Fenway Community Health | Boston | Massachusetts | 02115 | — |
| Harvard University / Brigham and Women's Hospital | Boston | Massachusetts | 02115 | — |
| Saint Louis University School of Medicine | St Louis | Missouri | 63110 | — |
| New York Blood Ctr / Union Square | New York | New York | 10003 | — |
| Columbia Univ | New York | New York | 10032 | — |
| Univ of Rochester Med Ctr | Rochester | New York | 14642 | — |
| Miriam Hosp | Providence | Rhode Island | 02906 | — |
| Vanderbilt Univ Hosp | Nashville | Tennessee | 37232 | — |
| Fred Hutchinson Cancer Research Ctr | Seattle | Washington | 98109 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00029913, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 1, 2010 · Synced Sep 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00029913 live on ClinicalTrials.gov.